Skip to main content
Admissions guidance, study banks, and career tools — get started on Shalyam
Research News

Early Statin Use May Lower Dementia Risk in People with Diabetes

Mayur Tembhare
  1. Over 132,000 people were tracked in the study, which was conducted in Denmark between 2006 and 2021.

  2. The researchers found that early statin use was associated with a 15% lower relative risk of dementia over 10 years.

  3. High levels of low-density lipoprotein cholesterol (LDL-C) are common among people with type 2 diabetes, and diabetes itself is a recognized risk factor for cognitive decline and dementia.

  4. The study suggests that statins may have benefits beyond their established role in protecting cardiovascular health.

Early Statin Use May Lower Dementia Risk in People with Diabetes

Topic: Health

Researchers found that people with type 2 diabetes who started taking statins soon after their diagnosis had a lower risk of developing dementia. The study, which followed over 132,000 people in Denmark, showed that early statin use was associated with a 15% lower relative risk of dementia over 10 years.

A recent study presented at the ESC Congress 2026 and published in The Lancet Regional Health - Europe found that starting statin treatment soon after a type 2 diabetes diagnosis was linked to a reduced risk of developing dementia. As populations age, the number of people living with dementia is expected to increase substantially. Currently, there are no effective treatments capable of preventing or reversing most forms of dementia, so researchers are focused on identifying factors that could reduce the likelihood of developing the condition.

One of the highlighted risk factors involves managing cholesterol beginning in midlife. High levels of low-density lipoprotein cholesterol (LDL-C) are common among people with type 2 diabetes, and diabetes itself is a recognized risk factor for cognitive decline and dementia. Doctor Tummas Ternhamar from Copenhagen University Hospital, Denmark explained that detecting and treating high LDL-C from midlife is one such highlighted risk factor.

The researchers used Danish national registers to track over 132,000 people who had not previously taken statins and developed type 2 diabetes between 2006 and 2019. They followed the participants through the end of 2021 and examined their medical records for diagnoses of all-cause dementia. The study found that compared with people who did not begin statin therapy, those who started statins within the first year after being diagnosed with type 2 diabetes had a 15% lower relative risk of dementia over 10 years.

Why It Matters

This research is important for Indian students because it highlights the importance of managing cholesterol levels and taking medication as prescribed to reduce the risk of developing dementia. As India's population ages, this is a growing concern that needs attention.

Key Facts

  • Over 132,000 people were tracked in the study, which was conducted in Denmark between 2006 and 2021.
  • The researchers found that early statin use was associated with a 15% lower relative risk of dementia over 10 years.
  • High levels of low-density lipoprotein cholesterol (LDL-C) are common among people with type 2 diabetes, and diabetes itself is a recognized risk factor for cognitive decline and dementia.
  • The study suggests that statins may have benefits beyond their established role in protecting cardiovascular health.
  • The research was observational, so it cannot establish that taking statins directly prevents dementia.

Key Terms

Statin
A type of medication that lowers cholesterol levels in the blood
LDL-C
Low-density lipoprotein cholesterol, a type of 'bad' cholesterol

Implications

This research is important for Indian students because it highlights the importance of managing cholesterol levels and taking medication as prescribed to reduce the risk of developing dementia. As India's population ages, this is a growing concern that needs attention.

Source: https://www.sciencedaily.com/releases/2026/09/260901070520.htm

Leave a comment

← All research

Get Exclusive Insights with Every Issue

Join Shalyam Newsletter

Stay ahead in education, research, and innovation—straight to your inbox.